Public Health Agency of Canada

"This dataset provides the cumulative number and percent of people in key populations who have received a COVID-19 vaccine in Canada, by number of doses and report week. Key populations are identified by the National Advisory Committee on Immunization and prioritized for early vaccination....

This dataset provides the cumulative number and percent of people who have received a COVID-19 vaccine in Canada by report week, number of doses, and jurisdiction. Variables include: Report week Jurisdiction ID number Jurisdiction Cumulative number vaccinated with at least 1 dose Cumulative...

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

Vaccines are the most effective way to prevent the spread of infectious disease, but developing one can be costly, long, and complex. A safe and effective vaccine will bring us one step closer to the widespread and long-term management of COVID-19.

The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.

Immunizing all Canadians with COVID-19 vaccine in a timely way will be a major challenge. In support of this massive undertaking, the Public Health Agency of Canada (PHAC) has developed planning guidance for the administration of COVID-19 vaccine.

The Government of Canada has established a number of advisory groups and task forces composed of stakeholders from the public sector, private sector and/or academia and research community, to provide recommendations or actions to address the COVID-19 pandemic in Canada.

COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021.

Canada is preparing to roll out an immunization response, which will provide Canadians with access to safe and effective vaccines to protect against COVID-19. This ambitious plan will be delivered through a principled and evidence-informed approach that puts protecting the health and safety of...

Learn about our vaccine progress, the safety of the authorization process and what vaccines have been authorized for use in Canada.

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

The Government of Canada is working on all possible fronts to secure access to safe and effective vaccines and related supplies for Canadians. Here is what Canadians need to know about a future COVID-19 vaccine.

The National Microbiology Laboratory (NML) provides critical scientific leadership for Canada’s response to COVID-19.

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

In 2018, 50% of Canadians had never been tested for HIV, hepatitis C, or STI.

"FluWatch is Canada's national surveillance system that monitors the spread of influenza and influenza-like illnesses on an ongoing basis. FluWatch reports, posted every Friday, contain information on flu activity in Canada. The FluWatch program consists of a network of labs, hospitals, doctor's...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.

Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This...